Lipid profiles in young HIV-infected children initiating and changing antiretroviral therapy.
about
Dyslipidemia, Diet and Physical Exercise in Children on Treatment With Antiretroviral Medication in El Salvador: A Cross-sectional StudyGetting to 90-90-90 in paediatric HIV: What is needed?Antiretroviral treatment in HIV-infected infants and young children: novel issues raised by the Mississippi babySex differences in responses to antiretroviral treatment in South African HIV-infected children on ritonavir-boosted lopinavir- and nevirapine-based treatment.Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy.The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected childrenThe changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents.Lipid changes in Kenyan HIV-1-infected infants initiating highly active antiretroviral therapy by 1 year of ageApolipoprotein B Gene Polymorphisms and Dyslipidemia in HIV Infected Adult Zimbabweans.Patterns of Growth, Body Composition, and Lipid Profiles in a South African Cohort of Human Immunodeficiency Virus-Infected and Uninfected Children: A Cross-Sectional Study.Nevirapine- Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy in HIV-Infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial.Association of Dyslipidemia and Glucose Abnormalities With Antiretroviral Treatment in a Cohort of HIV-Infected Latin American Children.Changes in elevated cholesterol in the era of tenofovir in South Africa: risk factors, clinical management and outcomes.Antiretroviral therapy during the neonatal period.Dietary patterns and nutritional status of HIV-infected children and adolescents in El Salvador: A cross-sectional study.Metabolic effects of initiating lopinavir/ritonavir-based regimens among young children
P2860
Q28395417-8ED0FE13-564D-4150-B9D0-A962B78DB135Q30385352-B11A91C7-8C12-478E-A1EF-DB5CF4BC3D07Q33557037-3CC82CC5-07F3-47A5-9B6A-DE97EE17B829Q35093189-DD321A45-E44A-4756-9ED1-5C282D129F0CQ35945312-91C7D603-CEEF-4675-80C8-5242A3EC2309Q36349683-E7E86B5A-4B52-46FF-8974-A519C32C9140Q36941665-FE1EED8B-7BAF-4EFD-8AEE-40BDCA02E298Q37080086-CBCC5E66-0010-4F43-8358-C944F135985BQ37350538-24305C50-08FD-4AEB-9021-737A8890902BQ38798094-2E027A0C-3B11-40DC-8709-CA61A996082BQ38853723-DECAC630-CEA2-47AE-80D1-5C2A72BB9529Q39444280-38ABE81C-5CC2-4FB1-B305-4C473D7EF4DDQ40278973-CF6F026E-8612-45ED-970A-AB256C95ED4CQ53801515-AFF7A003-B6EA-4D3D-A40A-69C931B38AB6Q55040771-F4FF8466-8BC0-4229-8628-50613AA62022Q57795380-61782A25-810D-4881-8ECE-4E13D52D5221
P2860
Lipid profiles in young HIV-infected children initiating and changing antiretroviral therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Lipid profiles in young HIV-in ...... anging antiretroviral therapy.
@ast
Lipid profiles in young HIV-in ...... anging antiretroviral therapy.
@en
type
label
Lipid profiles in young HIV-in ...... anging antiretroviral therapy.
@ast
Lipid profiles in young HIV-in ...... anging antiretroviral therapy.
@en
prefLabel
Lipid profiles in young HIV-in ...... anging antiretroviral therapy.
@ast
Lipid profiles in young HIV-in ...... anging antiretroviral therapy.
@en
P2093
P2860
P50
P1476
Lipid profiles in young HIV-in ...... anging antiretroviral therapy.
@en
P2093
Leigh Martens
Stephen Arpadi
Tammy Meyers
P2860
P304
P356
10.1097/QAI.0B013E318243760B
P407
P577
2012-08-01T00:00:00Z